Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep papanicolaou cytology

Journal of Lower Genital Tract Disease

Volumn 15, Issue 2, 2011, Pages 105-109

  Bansal, Mona ^a   Zhao, Chengquan ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

abnormal Pap test; African American; hrHPV; vaginal smears

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CYTOLOGY; FEMALE; HUMAN; PAPANICOLAOU TEST; PREVALENCE; RISK FACTOR; SQUAMOUS CELL; VAGINA SMEAR; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 79955057661     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181f41ee4     Document Type: Article

References (15)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9. (Pubitemid 29406813)
2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003;53:27-43. (Pubitemid 36163620)
3. ACOG Practice Bulletin. Cervical cytology screening. Number 45, August 2003. Int J Gynaecol Obstet 2003;83: 237-47.
4. Zhao C, Elishaev E, Yuan KH, Yu J, Austin RM. Very low human papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests. Cancer 2007;111:292-7.
5. Srodon M, Stoler MH, Baber GB, Kurman RJ. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 2006;30:1513-8. (Pubitemid 44808787)
6. Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008;17:1611-22.
7. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type - distribution in vul-var and vaginal cancers and their associated precursors. Obstet Gynecol 2009;113:917-24.
8. Logani S, Lu D, Quint WG, Ellenson LH, Pirog EC. Low-grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining. Mod Pathol 2003; 16:735-41. (Pubitemid 37011067)
9. Bandyopadhyay S, Austin RM, Dabbs D, Zhao C. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med 2008;132:1874-81.
10. Bansal M, Austin RM, Zhao C. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older. Gynecol Oncol 2009;115:257-61.
11. Zhao C, Austin RM. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone. Gynecol Oncol 2007; 107:231-5. (Pubitemid 47575717)
12. Zhao C, Zhao S, Heider A, Austin RM. Significance of high risk human papilloma virus DNA detection in women 50 years and older with squamous cell Papanicolaou test abnormalities. Arch Pathol Lab Med 2010;134:1130-5.
13. Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006;106:1054-64.
14. Kitchener HC, Almonte M, Wheeler P, Desai M, Gilham C, Bailey A, et al. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 2006;95:56-61. (Pubitemid 43980554)
15. Kendall BS, Zahn CM. The use of reflex high-risk human papillomavirus testing for atypical squamous cells of undetermined significance interpretations on vaginal specimens. Cancer Cytopathol 2009;117:27-31.